For the first time, weight-loss drugs come in two formats: the familiar weekly injections (semaglutide, tirzepatide) and a new wave of daily pills (orforglipron/Foundayo, oral Wegovy). The simple rule of 2026: injections still win on maximum weight loss, pills win on convenience and — often — cost and access.
Tirzepatide injections top ~20%; the pills land around 11–17%. Here is the honest pills-vs-injections breakdown so you can see the real trade-off.
The 2026 lineup
A quick map of what is actually out there, by format:
- Injections (weekly): semaglutide (Ozempic for diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro / Zepbound). The established, most powerful options. The investigational retatrutide would join this group if approved.
- Pills (daily): orforglipron, approved as Foundayo (a once-daily small-molecule GLP-1), and oral Wegovy (a 25 mg semaglutide tablet). Both are new in 2026.
That split — weekly shot versus daily pill — is the choice that did not meaningfully exist a year ago. We cover the pill side in orforglipron (Foundayo) in Canada and the oral Wegovy pill.
Weight loss by format
These come from different trials, so read them as a directional ranking, not a head-to-head.
| Drug | Format | Weight loss |
|---|---|---|
| Tirzepatide (Zepbound) | Weekly injection | ~20.2% (SURMOUNT-5) |
| Oral Wegovy | Daily pill | ~16.6% (OASIS-4) |
| Semaglutide (Wegovy) | Weekly injection | ~13.7% (SURMOUNT-5) |
| Orforglipron (Foundayo) | Daily pill | ~11.2% vs 2.1% placebo |
Notice something interesting: oral Wegovy (a pill) out-performed semaglutide injection in these separate readouts, because it is a higher-dose formulation of the same drug. So “pill = weaker” is already too simple. But the single biggest number still belongs to an injection: tirzepatide.
The strongest drug is still a weekly shot. But the gap between “most powerful” and “most convenient” is the smallest it has ever been.Pills vs injections, 2026
Why injections still win on power
The most effective weight-loss drug on the market is a weekly injection: tirzepatide, at about 20% weight loss. The investigational triple agonist retatrutide, also injectable, has posted even higher figures in trials. There are two reasons the heavy hitters are injectable.
First, absorption. Peptide drugs are fragile and absorb poorly when swallowed, so an injection delivers the active drug far more reliably. Second, the molecules themselves: the most powerful agents (tirzepatide, retatrutide) are peptides built for injection. Getting that level of potency into a pill is chemically hard, which is why the pills tend to land a step below the strongest shots.
Why pills are a big deal anyway
If injections are stronger, why is everyone excited about pills? Because effectiveness in a trial is not the same as effectiveness in real life, where people have to actually take the drug.
- No needle. Needle aversion keeps a lot of people off injectables entirely. A pill removes that barrier.
- Easier to scale and ship. Orforglipron is a small molecule, not a peptide, so it is simpler and cheaper to manufacture and does not need the cold-chain handling injectable peptides do. That can mean broader, cheaper supply.
- Lower starting price. Foundayo launched in the U.S. at roughly $149–$349 a month cash depending on dose — and far less with insurance and manufacturer support — undercutting the sticker price of brand injectables.
A slightly smaller average weight loss that far more people can access and stick with can add up to more real-world benefit than a stronger drug people never start. That is the pills’ genuine argument.
Cost and access
Format increasingly drives price. Injectable semaglutide is getting cheaper in Canada thanks to generics (see Sevmia and generic Wegovy), while tirzepatide, with no generic yet, stays pricier. On the pill side, orforglipron’s small-molecule chemistry points to lower long-run costs, though Canadian pricing and availability for the newest pills are still being established.
The practical reality in Canada as of October 2026: injectable semaglutide and tirzepatide are approved and accessible through a clinician, injectable semaglutide now has cheaper generics, and the newest pills (oral Wegovy, and orforglipron) are either pending Health Canada review or newly arriving. Availability is moving month to month.
Which is right for you
There is no universal winner — it depends on what you are optimising for:
- Maximum weight loss: an injection (tirzepatide today) leads.
- No needles / daily routine preference: a pill (oral Wegovy, orforglipron).
- Lowest cost in Canada right now: generic injectable semaglutide.
- A cardiac history or other medical factors: this is exactly where a doctor’s input matters most.
This is a genuine medical decision with trade-offs beyond the scale, so the real next step is a conversation with a doctor or pharmacist, not a blog. None of this is medical advice.
Myths
“Myth: Pills are always weaker than injections.”
Not always. Oral Wegovy (~16.6%) out-performed injectable semaglutide (~13.7%) in separate trials. The strongest option is still an injection (tirzepatide), but the pill-vs-shot gap is not a simple ranking.
“Myth: Orforglipron is just another peptide in a pill.”
Orforglipron is a small molecule, not a peptide. That is the point: it is easier to make, does not need cold-chain shipping, and is designed for oral dosing from the ground up.
“Myth: If I can’t get the pill, there’s nothing good available.”
Injectable semaglutide and tirzepatide are approved and effective, and semaglutide is now cheaper in Canada thanks to generics. The pills are an addition to the menu, not the only good option.
“Myth: I can just buy whichever format online.”
All of these are prescription medicines. Buying unauthorized injectable peptides online is illegal in Canada, and a research-use label gives no exemption. The legal route is a prescription through a clinician.
For researchers
TrueLabs does not sell any of these as medicines. It supplies research-grade reference peptides in CAD, for in vitro and laboratory research only, never for human or veterinary use, including TZ-2 (tirzepatide) from $73 and RT3 (retatrutide) from $90. The oral-versus-injectable question is a real one in peptide science — see BPC-157 oral vs injectable and, for documentation, how to read a peptide COA.
FAQ
Tap a question to reveal the answer.
Are weight-loss pills as effective as injections?
Not quite at the top end. The strongest option is an injection — tirzepatide at about 20% weight loss. The best pill, oral Wegovy, reaches about 16.6%, and orforglipron about 11%. But pills can match or beat older injections and are easier to take, which matters in real life.
What weight-loss pills are available in 2026?
Two new ones: orforglipron (approved as Foundayo, a daily small-molecule GLP-1) and oral Wegovy (a 25 mg daily semaglutide tablet). Rybelsus (oral semaglutide) also exists for diabetes with a smaller weight effect.
Why are the strongest weight-loss drugs injectable?
Because the most potent agents (tirzepatide, retatrutide) are peptides that absorb poorly when swallowed. An injection delivers them reliably, so the heavy hitters are injectable while pills tend to land a step below.
Is orforglipron a peptide?
No. Orforglipron is a small molecule, which makes it cheaper to manufacture and ship (no cold chain) and well suited to a daily pill — a key reason it is seen as a potential access breakthrough.
Which is cheaper, a pill or an injection?
It is shifting. Injectable semaglutide is now cheap in Canada thanks to generics. Orforglipron’s small-molecule chemistry points to low long-run costs. Brand injectable tirzepatide, with no generic, tends to be the priciest.
Are these pills available in Canada?
Injectable semaglutide and tirzepatide are approved and accessible. The newest pills (oral Wegovy, orforglipron) are pending Health Canada review or newly arriving as of October 2026 — availability is changing month to month.
Should I choose a pill or an injection?
It depends: an injection for maximum weight loss, a pill to avoid needles, generic injectable semaglutide for lowest cost in Canada. Medical factors like a cardiac history matter too, so decide with a doctor or pharmacist.
Can I buy these without a prescription?
No. All are prescription medicines. Unauthorized injectable peptides sold online are illegal in Canada, and research-grade material is for laboratory use only, not human use.
Related reading
- Orforglipron (Foundayo) in Canada
- The oral Wegovy pill in Canada
- Tirzepatide vs semaglutide
- Sevmia and generic Wegovy in Canada
- The next weight-loss drugs after Ozempic
References
- FDA approves Eli Lilly’s orforglipron (Foundayo) weight-loss pill; 11.2% at 36 mg vs 2.1% placebo (about April 1, 2026). ADN / AP. ADN / AP
- FDA approves oral Wegovy (oral semaglutide 25 mg); OASIS-4 ~16.6% (December 22, 2025). Epocrates. Epocrates
- Tirzepatide bests semaglutide for weight loss: SURMOUNT-5 (20.2% vs 13.7%). TCTMD. TCTMD
- Health Canada. Think twice before injecting peptides bought online (advisory, April 9, 2026). Health Canada
This article summarizes published research and regulatory information for information only and is not medical advice. TrueLabs research compounds are sold for in vitro and laboratory research use only and are not intended for human or veterinary use.